Baillie Gifford - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$4,418
-43.9%
2,5100.0%0.00%
Q4 2022$7,881
-34.3%
2,5100.0%0.00%
Q3 2022$12,000
+20.0%
2,5100.0%0.00%
Q2 2022$10,0002,5100.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Lombard Odier Asset Management (Switzerland) SA 1,539,994$11,550,0000.74%
Golden State Equity Partners 143,768$1,078,0000.54%
Rhenman & Partners Asset Management AB 765,000$5,975,0000.40%
WASATCH ADVISORS LP 10,960,982$82,207,0000.34%
KLK CAPITAL MANAGEMENT LLC 44,323$332,0000.32%
EMC Capital Management 61,394$460,0000.25%
Rokos Capital Management LLP 539,860$4,108,0000.25%
Long Focus Capital Management, LLC 245,000$1,838,0000.24%
Vanguard Capital Wealth Advisors 33,380$250,0000.18%
Fort Sheridan Advisors LLC 74,898$562,0000.16%
View complete list of SANGAMO THERAPEUTICS INC shareholders